Medicine
Triazolam 0.125 mg tablet
Triazolam 0.125 mg tablet is a generic prescription medicine for oral use, made by 3 labelers, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Ambient
Store at controlled room temperature 20° to 25°C (68° to 77°F).
Key facts
- Active ingredient (INN)
- Triazolam
- Brand
- Sold under the generic name
- Strength
- 0.125 mg
- Dosage form
- Tablet
- Route
- Oral
- Packs
- 100 tablets, 500 tablets, 10 tablets and 5 more
- Manufacturers
- Zydus LifesciencesIndiaIngenus PharmaceuticalsMylan Pharmaceuticals
- Origin register
- US FDA, United States
- Storage
- Store at controlled room temperature 20° to 25°C (68° to 77°F).
- Cold chain
- Not required on record
- Prescription status
- Prescription only
- Controlled substance
- Schedule CIV
- ATC code
- N05CD05 Triazolam
- HS code (indicative)
- 3004.90Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 15 November 1982
- Identifiers
- RxCUI 198317, 198318DailyMed set ID 5add318e-11b9-42f8-b052-0d8cebb32fcf, 4084da13-5825-4399-ad69-de701508c71d, a0c99f0b-4122-4611-9b53-80fadfceacb6 +1NDC 59762-3717, 70771-1576, 50742-645 +1Application NDA017892, ANDA213003, ANDA214219
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
Packs from every labeler of this generic presentation.
| Pack | Code | Labeler | Marketed since |
|---|---|---|---|
| 100 tablet in 1 bottle | 70710-1521-1 | Zydus LifesciencesIndia | 30 December 2022 |
| 500 tablet in 1 bottle | 70710-1521-5 | Zydus LifesciencesIndia | 30 December 2022 |
| 10 tablet in 1 bottle | 70710-1521-8 | Zydus LifesciencesIndia | 30 December 2022 |
| 100 tablet in 1 bottle | 70771-1576-1 | Zydus LifesciencesIndia | 30 December 2022 |
| 500 tablet in 1 bottle | 70771-1576-5 | Zydus LifesciencesIndia | 30 December 2022 |
| 10 tablet in 1 bottle | 70771-1576-8 | Zydus LifesciencesIndia | 30 December 2022 |
| 100 tablet in 1 bottle, plastic | 50742-645-01 | Ingenus Pharmaceuticals | 20 October 2020 |
| 100 tablet in 1 bottle | 59762-3717-9 | Mylan Pharmaceuticals | 13 January 2017 |
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
| Register | Status | Source |
|---|---|---|
| US FDA | Listed, marketed | Source record for this pageChecked 12 November 2026 |
| US FDA | First approved 15 November 1982 | Drugs@FDA |
| EU (EMA) | Not recorded | — |
| India (CDSCO) | Not yet confirmed against CDSCO approval lists | — |
| United States | Registered | US FDA (NDC directory, openFDA)Checked 12 November 2026 |
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Other strengths and forms of Triazolam
Clinical summary
Triazolam is a benzodiazepine indicated for the short-term treatment of insomnia (generally 7 to 10 days) in adults. It is available as tablets for oral use. MedsAcross supplies Triazolam for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about TriazolamFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- Triazolam prescribing information (Mylan Pharmaceuticals) · U.S. National Library of Medicine, DailyMed
Need Triazolam 0.125 mg tablet for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.